BB-301 Momentum, Favorable FDA Feedback Support Buy Rating with Unchanged $32 Price Target
at www.tipranks.com (Tue, 6-Oct 7:05 AM)
FDA Clarity on BB-301 Phase 3 Supports Buy Rating on BNTC; $17 Price Target Reiterated
at www.tipranks.com (Mon, 5-Oct 2:25 PM)
Benitec advances BB-301 gene therapy after FDA feedback
at www.tipranks.com (Mon, 5-Oct 8:28 AM)
